Efavirenz significantly affects pharmacokinetic exposure of artemether-lumefantrine in HIV-infected Ugandan adults

被引：0
作者：
Byakika-Kibwika, P. [1 ]
机构：
[1] Makerere Univ, Infect Dis Inst, Kampala, Uganda
来源：
TROPICAL MEDICINE & INTERNATIONAL HEALTH | 2012年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：40 / 41
页数：2
相关论文
共 50 条
[31]   Pharmacokinetic properties of the antimalarial combination therapy artemether-lumefantrine in normal-weight, overweight and obese healthy male adults [J].
Sugiarto, Sri Riyati ;
Page-Sharp, Madhu ;
Drinkwater, Jocelyn J. ;
Davis, Wendy A. ;
Salman, Sam ;
Davis, Timothy M. E. .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2022, 59 (01)
[32]   Efavirenz but Not Atazanavir/Ritonavir Significantly Reduces Atovaquone Concentrations in HIV-Infected Subjects [J].
Calderon, Monica M. ;
Penzak, Scott R. ;
Pau, Alice K. ;
Kumar, Parag ;
McManus, Maryellen ;
Alfaro, Raul M. ;
Kovacs, Joseph A. .
CLINICAL INFECTIOUS DISEASES, 2016, 62 (08) :1036-1042
[33]   Impact of Drug Exposure on Resistance Selection Following Artemether-Lumefantrine Treatment for Malaria in Children With and Without HIV in Uganda [J].
Kay, Katherine ;
Goodwin, Justin ;
Ehrlich, Hanna ;
Ou, Joyce ;
Freeman, Tracey ;
Wang, Kaicheng ;
Li, Fangyong ;
Wade, Martina ;
French, Jonathan ;
Huang, Liusheng ;
Aweeka, Francesca ;
Mwebaza, Norah ;
Kajubi, Richard ;
Riggs, Matthew ;
Ruiz-Garcia, Ana ;
Parikh, Sunil .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 (03) :660-669
[34]   The interaction between artemether-lumefantrine and lopinavir/ritonavir-based antiretroviral therapy in HIV-1 infected patients [J].
T. Kredo ;
K. Mauff ;
L. Workman ;
J. S. Van der Walt ;
L. Wiesner ;
P. J. Smith ;
G. Maartens ;
K. Cohen ;
K. I. Barnes .
BMC Infectious Diseases, 16
[35]   The interaction between artemether-lumefantrine and lopinavir/ritonavir-based antiretroviral therapy in HIV-1 infected patients [J].
Kredo, T. ;
Mauff, K. ;
Workman, L. ;
Van der Walt, J. S. ;
Wiesner, L. ;
Smith, P. J. ;
Maartens, G. ;
Cohen, K. ;
Barnes, K. I. .
BMC INFECTIOUS DISEASES, 2016, 16
[36]   Effect of antiretroviral therapy on malaria incidence in HIV-infected Ugandan adults [J].
Kasirye, Ronnie P. ;
Grosskurth, Heiner ;
Munderi, Paula ;
Levin, Jonathan ;
Anywaine, Zacchaeus ;
Nunn, Andrew ;
Kamali, Anatoli ;
Baisley, Kathy .
AIDS, 2017, 31 (04) :577-582
[37]   Steady-state Pharmacokinetic Comparison of Generic and Branded Formulations of Lamivudine, Stavudine, and Nevirapine in HIV-infected Ugandan Adults [J].
Byakika-Kibwika, P. ;
Lamorde, M. ;
Kalemeera, F. ;
D'Avolio, A. ;
Mauro, S. ;
Di Perri, G. ;
Ryan, M. ;
Khoo, S. ;
Boffito, M. ;
Merry, C. .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 :E199-E199
[38]   Steady-state pharmacokinetic comparison of generic and branded formulations of stavudine, lamivudine and nevirapine in HIV-infected Ugandan adults [J].
Byakika-Kibwika, Pauline ;
Lamorde, Mohammed ;
Kalemeera, Francis ;
D'Avolio, Antonio ;
Mauro, Sciandra ;
Di Perri, Giovanni ;
Ryan, Mairin ;
Mayanja-Kizza, Harriet ;
Khoo, Saye ;
Back, David ;
Boffito, Marta ;
Merry, Concepta .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (05) :1113-1117
[39]   Population Pharmacokinetic/Pharmacogenetic Model for Optimization of Efavirenz Therapy in Caucasian HIV-Infected Patients [J].
Sanchez, Almudena ;
Cabrera, Salvador ;
Santos, Dolores ;
Paz Valverde, M. ;
Fuertes, Aurelio ;
Dominguez-Gil, Alfonso ;
Garcia, Maria J. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (11) :5314-5324
[40]   Profile of immunologic recovery in HIV-infected Ugandan adults after antiretroviral therapy [J].
Baker, Chris A. R. ;
Emenyonu, Nneka ;
Ssewanyana, Isaac ;
Jones, Norman G. ;
Elrefaei, Mohamed ;
Nghania, Frehd ;
Nakiwala, Justine ;
Andia, Irene ;
Clark, Richard ;
Martin, Jeffrey ;
Bangsberg, David R. ;
Cao, Huyen .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2007, 23 (07) :900-905
12345